Formed in 2003, Victory Pharma, markets prescription pharmaceutical products. From its inception, Victory's strategy has focused on acquiring and developing products to generate significant sales and build a strong financial base. As the Company evolved, an intellectual property platform was acquired which is suitable for multiple pain therapy development programs. These programs are now being advanced into clinical trials. From this solid foundation, Victory is transforming into a high-growth pain specialty pharmaceutical firm. Victory's experienced management team is comprised of successful executives from specialty drug ventures such as Dura Pharmaceuticals, DJ Pharma and Xcel Pharmaceuticals.